- Home
- RWT vs CSTL Comparison
RWT vs CSTL Comparison
Compare RWT & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RWT | CSTL |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 693.0M | 661.7M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RWT | CSTL |
|---|---|---|
| Price | $5.64 | $39.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $7.00 | ★ $40.67 |
| AVG Volume (30 Days) | ★ 1.1M | 461.5K |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | ★ 12.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $120,897,000.00 | ★ $343,530,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | $46.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10.15 |
| 52 Week Low | $4.68 | $14.59 |
| 52 Week High | $7.19 | $40.61 |
Technical Indicators
Market Signals| Indicator | RWT | CSTL |
|---|---|---|
| Relative Strength Index (RSI) | 59.27 | 69.78 |
| Support Level | $5.45 | $36.63 |
| Resistance Level | $5.70 | $40.54 |
| Average True Range (ATR) | 0.13 | 1.31 |
| MACD | 0.03 | -0.48 |
| Stochastic Oscillator | 89.29 | 60.55 |
Price Performance
Historical ComparisonAbout RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.